FDA Conducting Evaluation of Key Agency Activities to Strengthen Operations
In February 2022, I rejoined the U.S. Food and Drug Administration as Commissioner of Food and Drugs, having served in the role five years earlier.…
Category News
Read More
FDA Provides Educational Resources for Parents and Caregivers to Support Confidence for Imported Infant Formula Products
Today, the U.S. Food and Drug Administration announced the availability of educational resources for parents and caregivers with questions about using the hundreds of millions of bottles…
Urgent call for better use of existing vaccines and development of new vaccines to tackle AMR
The World Health Organization today released the first-ever report on the pipeline of the vaccines currently in development to prevent infections caused by antimicrobial-resistant (AMR)…
WHO’s Science Council launches report calling for equitable expansion of genomics
WHO’s Science Council of experts has issued its first report, on accelerating access to genomics for global health. The report argues that it is not justifiable ethically or…
FDA Warns Four Companies for Selling Tainted Honey-based Products with Hidden Active Drug Ingredients
Today, the U.S. Food and Drug Administration (FDA) issued warning letters to four companies for illegally selling honey-based products that may pose a significant health…
FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for U.S. Parents and Caregivers
The need to diversify and strengthen the U.S. infant formula supply is more important than ever. The recent shutdown of a major infant formula plant,…
Teva Announces Appointment of New Global R&D and Chief Medical Officer
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eric A. Hughes, MD, PhD as Executive Vice President, Global R&D and…
FDA Introduces Innovative Proposal to Advance Consumer Access to Nonprescription Drugs
Today, the U.S. Food and Drug Administration issued a proposed rule titled, “Nonprescription Drug Product with an Additional Condition for Nonprescription Use,” which is intended…
FDA Releases Action Plan for Rare Neurodegenerative Diseases, Including ALS
Today, the U.S. Food and Drug Administration unveiled its Action Plan for Rare Neurodegenerative Diseases including Amyotrophic Lateral Sclerosis (ALS) – a five-year strategy for improving and…
Vividion Therapeutics names Aleksandra Rizo as President and Head of Research and Development
Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune…
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
Novartis endorses the Kigali Declaration on neglected tropical diseases, pledging USD 250 million to advance R&D of new treatments against NTDs and malaria over five…
Lack of innovation set to undermine antibiotic performance and health gains
Development of new antibacterial treatments is inadequate to address the mounting threat of antibiotic resistance, according to the annual pipeline report by the World Health…